homocysteine has been researched along with dactinomycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finkelstein, JD; Harris, BJ; Kyle, W | 1 |
Aarbakke, J; Endresen, PC; Lysne, S; Prytz, PS | 1 |
Branchereau, A; Garçon, D; Jourdheuil-Rahmani, D; Rolland, PH; Rosset, E | 1 |
Abcouwer, SF; Hurtado, D; Roybal, CN; Sun, CW; Townes, TM; Vander Jagt, DL; Yang, S | 1 |
Chang, KL; Huang, LW; Liu, HW; Pai, LS; Su, SJ | 1 |
Anfossi, G; Doronzo, G; Mattiello, L; Russo, I; Trovati, M | 1 |
6 other study(ies) available for homocysteine and dactinomycin
Article | Year |
---|---|
Methionine metabolism in mammals. Regulation of homocysteine methyltransferases in rat tissue.
Topics: Aging; Alloxan; Animals; Betaine; Chromatography, Gel; Cycloheximide; Cysteine; Dactinomycin; Dietary Proteins; Enzyme Induction; Enzyme Repression; Glucagon; Homocysteine; Hormones; Liver; Male; Methionine; Methyltransferases; Organ Specificity; Rats; Tetrahydrofolates; Ultracentrifugation | 1971 |
Homocysteine increases the relative number of apoptotic cells and reduces the relative number of apoptotic bodies in HL-60 cells treated with 3-deazaadenosine.
Topics: Apoptosis; Cycloheximide; Dactinomycin; DNA; Homocysteine; Humans; Interphase; Leukemia, Promyelocytic, Acute; Tubercidin; Tumor Cells, Cultured | 1994 |
Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors.
Topics: Adult; Cells, Cultured; Cycloheximide; Dactinomycin; Enzyme Activation; Homocysteine; Humans; Muscle, Smooth, Vascular; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Serine Endopeptidases; Time Factors | 1997 |
Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4.
Topics: Activating Transcription Factor 4; Blotting, Northern; Blotting, Western; Carrier Proteins; CCAAT-Enhancer-Binding Proteins; Cell Line; Cell Nucleus; Dactinomycin; DNA, Complementary; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Genes, Dominant; Heat-Shock Proteins; Homocysteine; Humans; Molecular Chaperones; Mutation; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Physiological; Time Factors; Transcription Factor CHOP; Transcription Factors; Transcription, Genetic; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression.
Topics: Adult; Biomarkers; Cells, Cultured; Cycloheximide; Cytokines; Dactinomycin; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression Regulation; Homocysteine; Humans; Macrophage Migration-Inhibitory Factors; Male; Monocytes; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Vascular Diseases | 2005 |
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways.
Topics: Aorta; Cell Movement; Cells, Cultured; Chromones; Dactinomycin; Dose-Response Relationship, Drug; Flavonoids; Homocysteine; Humans; Matrix Metalloproteinase 2; Mitogen-Activated Protein Kinases; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphoinositide-3 Kinase Inhibitors; Protein Synthesis Inhibitors; Signal Transduction; Time Factors | 2005 |